retatrutide drug Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation

Switching from Semaglutide to Tirzepatide: Reasons, Safety & Dosage for Weight Loss Tirzepatide vs Semaglutide: Cost, Side Effects, & Dosage Mochi Health TrimRX GLP 1 vs GIP: Understanding Dual Agonist Medications The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide